Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania

Annals of Internal Medicine

Volumn 160, Issue 2, 2014, Pages 91-100

  Fitzpatrick, Meagan C ^a   Hampson, Katie ^b   Cleaveland, Sarah ^b   Mzimbiri, Imam ^c   Lankester, Felix ^d   Lembo, Tiziana ^b   Meyers, Lauren A ^c   Paltiel, A David ^a   Galvani, Alison P ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Washington State University ^*  (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE TRANSMISSION; DOG; DOG BITE; DRUG COST; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RABIES; RURAL AREA; SENSITIVITY ANALYSIS; TANZANIA; UNCERTAINTY; VACCINATION; WILDLIFE;

ANIMALS; BITES AND STINGS; COST-BENEFIT ANALYSIS; DOG DISEASES; DOGS; HUMANS; MODELS, STATISTICAL; RABIES; RABIES VACCINES; RURAL POPULATION; TANZANIA; VACCINATION;

EID: 84893329661     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-0542     Document Type: Article

References (39)

1. World Health Organization. WHO Expert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser. 2013:1-139, back cover. [PMID: 24069724]
2. Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, Miranda ME, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005;83:360-8. [PMID: 15976877]
3. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol. 2002;1:101-9. [PMID: 12849514]
4. WHO Expert Consultation on rabies. World Health Organ Tech Rep Ser. 2005;931:1-88, back cover. [PMID: 16485446]
5. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec. 2007;82:425-35. [PMID: 18064757]
6. Quiambao BP, Dimaano EM, Ambas C, Davis R, Banzhoff A, Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 mL PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine. 2005;23:1709-14. [PMID: 15705476]
7. Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, et al. The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis. 2010;4:e626. [PMID: 20186330]
8. Zinsstag J, Dürr S, Penny MA, Mindekem R, Roth F, Menendez Gonzalez S, et al. Transmission dynamics and economics of rabies control in dogs and humans in an African city. Proc Natl Acad Sci U S A. 2009;106:14996-5001. [PMID: 19706492]
9. Fitzpatrick MC, Hampson K, Cleaveland S, Meyers LA, Townsend JP, Galvani AP. Potential for rabies control through dog vaccination in wildlifeabundant communities of Tanzania. PLoS Negl Trop Dis. 2012;6:e1796. [PMID: 22928056]
10. Beyer HL, Hampson K, Lembo T, Cleaveland S, Kaare M, Haydon DT. The implications of metapopulation dynamics on the design of vaccination campaigns. Vaccine. 2012;30:1014-22. [PMID: 22198516]
11. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M (eds). National Burden of Disease Studies: A Practical Guide, Edition 2.0. Health Policy. Geneva: World Health Organization; 2001. Accessed at www.who.int/healthinfo/ nationalburdenofdiseasemanual.pdf on 13 November 2013.
12. Meltzer MI, Rupprecht CE. A review of the economics of the prevention and control of rabies. Part 2: rabies in dogs, livestock and wildlife. Pharmacoeconomics. 1998;14:481-98. [PMID: 10344914]
13. World Health Organization. Commission on Macroeconomics and Health. Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization; 2001.
14. Choosing Interventions That Are Cost-Effective (WHO-CHOICE). Geneva: World Health Organization; 2010. Accessed at www.who.int/choice/en on 13 November 2013.
15. The World Bank. Tanzania. Accessed at http://data.worldbank.org/country/ tanzania on 1 August 2013.
16. Lembo T, Hampson K, Haydon DT, Craft M, Dobson A, Dushoff J, et al. Exploring reservoir dynamics: a case study of rabies in the Serengeti ecosystem. J Appl Ecol. 2008;45:1246-1257. [PMID: 22427710]
17. Hampson K, Dushoff J, Cleaveland S, Haydon DT, Kaare M, Packer C, et al. Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol. 2009;7:e53. [PMID: 19278295]
18. Kaare M, Lembo T, Hampson K, Ernest E, Estes A, Mentzel C, et al. Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. Vaccine. 2009;27:152-60. [PMID: 18848595]
19. Coleman PG, Dye C. Immunization coverage required to prevent outbreaks of dog rabies. Vaccine. 1996;14:185-6. [PMID: 8920697]
20. Kitala PM, McDermott JJ, Coleman PG, Dye C. Comparison of vaccination strategies for the control of dog rabies in Machakos District, Kenya. Epidemiol Infect. 2002;129:215-22. [PMID: 12211590]
21. Hampson K, Dushoff J, Bingham J, Brückner G, Ali YH, Dobson A. Synchronous cycles of domestic dog rabies in sub-Saharan Africa and the impact of control efforts. Proc Natl Acad Sci U S A. 2007;104:7717-22. [PMID: 17452645]
22. Hampson K, Dobson A, Kaare M, Dushoff J, Magoto M, Sindoya E, et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis. 2008;2:e339. [PMID: 19030223]
23. Cleaveland S, Fèvre EM, Kaare M, Coleman PG. Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bull World Health Organ. 2002;80:304-10. [PMID: 12075367]
24. Shim E, Hampson K, Cleaveland S, Galvani AP. Evaluating the Cost-Effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine. 2009;27:7167-72. [PMID: 19925948]
25. Laurenson MK, Mlengeya T, Shiferaw F, Cleaveland S. Approaches to disease control in domestic canids for the conservation of endangered wild carnivores. Occasional Papers of the IUCN Species Survival Commission. 2005;30:141-6.
26. Randall DA, Marino J, Haydon DT, Sillero-Zubiri C, Knobel DL, Tallents LA, et al. An integrated disease management strategy for the control of rabies in Ethiopian wolves. Biological Conservation. 2006;131:151-62.
27. Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making. 2002;22:290-308. [PMID: 12150595]
28. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18:S68-80. [PMID: 9566468]
29. Tanzania Global Health Initiative Strategy 2010-2015. Washington, DC; 2011. Accessed at www.ghi.gov/whereWeWork/docs/TanzaniaStrategy.pdf on 18 November 2013.
30. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care. 2008;46:349-56. [PMID: 18362813]
31. Bögel K, Meslin FX. Economics of human and canine rabies elimination: guidelines for programme orientation. Bull World Health Organ. 1990;68:281-91. [PMID: 2118428]
32. Schneider MC, Belotto A, Adé MP, Hendrickx S, Leanes LF, Rodrigues MJ, et al. Current status of human rabies transmitted by dogs in Latin America. Cad Saude Publica. 2007;23:2049-63. [PMID: 17700940]
33. Cliquet F, Robardet E, Must K, Laine M, Peik K, Picard-Meyer E, et al. Eliminating rabies in Estonia. PLoS Negl Trop Dis. 2012;6:e1535. [PMID: 22393461]
34. McNeil DG Jr. Rabies: Rabies Outbreak in Angola, Caused by Roaming Dogs, Kills 93 Children. The New York Times; 2009. Accessed at www.nytimes.com/2009/ 03/17/health/17glob.html?-r=0 on 18 November 2013.
35. Hampson K, Cleaveland S, Briggs D. Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries. PLoS Negl Trop Dis. 2011;5:e982. [PMID: 21408121]
36. Davlin SL, Vonville HM. Canine rabies vaccination and domestic dog population characteristics in the developing world: a systematic review. Vaccine. 2012;30:3492-502. [PMID: 22480924]
37. Brooks R. Survey of the dog population of Zimbabwe and its level of rabies vaccination. Vet Rec. 1990;127:592-6. [PMID: 2075689]
38. Minke JM, Bouvet J, Cliquet F, Wasniewski M, Guiot AL, Lemaitre L, et al. Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Vet Microbiol. 2009;133:283-6. [PMID: 18757142]
39. Kayali U, Mindekem R, Yémadji N, Vounatsou P, Kaninga Y, Ndoutamia AG, et al. Coverage of pilot parenteral vaccination campaign against canine rabies in N'Djaména, Chad. Bull World Health Organ. 2003;81:739-44. [PMID: 14758434]